Bond JH - Search Results

1

Validation of a questionnaire to assess self-reported colorectal cancer screening status using face-to-face administration.

Fisher DA, Voils CI, Coffman CJ, Grubber JM, Dudley TK, Vernon SW, Bond JH, Provenzale D. Fisher DA, et al. Among authors: bond jh. Dig Dis Sci. 2009 Jun;54(6):1297-306. doi: 10.1007/s10620-008-0471-z. Epub 2008 Aug 23. Dig Dis Sci. 2009. PMID: 18726152 Free PMC article.

2

Five-year colon surveillance after screening colonoscopy.

Lieberman DA, Weiss DG, Harford WV, Ahnen DJ, Provenzale D, Sontag SJ, Schnell TG, Chejfec G, Campbell DR, Kidao J, Bond JH, Nelson DB, Triadafilopoulos G, Ramirez FC, Collins JF, Johnston TK, McQuaid KR, Garewal H, Sampliner RE, Esquivel R, Robertson D. Lieberman DA, et al. Among authors: bond jh. Gastroenterology. 2007 Oct;133(4):1077-85. doi: 10.1053/j.gastro.2007.07.006. Gastroenterology. 2007. PMID: 17698067 Clinical Trial.

3

Screening guidelines for colorectal cancer.

Bond JH. Bond JH. Am J Med. 1999 Jan 25;106(1A):7S-10S. doi: 10.1016/s0002-9343(98)00339-8. Am J Med. 1999. PMID: 10089107 Review.

4

Fecal occult blood test screening for colorectal cancer.

Bond JH. Bond JH. Gastrointest Endosc Clin N Am. 2002 Jan;12(1):11-21. doi: 10.1016/s1052-5157(03)00054-0. Gastrointest Endosc Clin N Am. 2002. PMID: 11916154 Review.

5

Colorectal cancer screening.

Bond JH. Bond JH. Curr Opin Oncol. 1998 Sep;10(5):461-6. doi: 10.1097/00001622-199809000-00016. Curr Opin Oncol. 1998. PMID: 9800118 Review.

6

Long-term mortality after screening for colorectal cancer.

Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, Church TR. Shaukat A, et al. Among authors: bond jh. N Engl J Med. 2013 Sep 19;369(12):1106-14. doi: 10.1056/NEJMoa1300720. N Engl J Med. 2013. PMID: 24047060 Free article. Clinical Trial.

7

Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs.

Sawhney MS, McDougall H, Nelson DB, Bond JH. Sawhney MS, et al. Among authors: bond jh. Dig Dis Sci. 2010 Jun;55(6):1637-42. doi: 10.1007/s10620-010-1150-4. Epub 2010 Mar 3. Dig Dis Sci. 2010. PMID: 20195757

8

The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective.

Bond JH. Bond JH. Am J Gastroenterol. 2006 Feb;101(2):219-21. doi: 10.1111/j.1572-0241.2006.00486.x. Am J Gastroenterol. 2006. PMID: 16454821 No abstract available.

9

Fecal occult blood testing for colorectal cancer. Can we afford not to do this?

Bond JH. Bond JH. Gastroenterol Clin North Am. 1997 Mar;26(1):57-70. doi: 10.1016/s0889-8553(05)70283-1. Gastroenterol Clin North Am. 1997. PMID: 9119440 Review.

10

Is BRAF mutation associated with interval colorectal cancers?

Shaukat A, Arain M, Thaygarajan B, Bond JH, Sawhney M. Shaukat A, et al. Among authors: bond jh. Dig Dis Sci. 2010 Aug;55(8):2352-6. doi: 10.1007/s10620-010-1182-9. Epub 2010 Mar 19. Dig Dis Sci. 2010. PMID: 20300843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page